As of 4:00pm ET
| +1.37 / +2.69%|
The 4 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 51.00, with a high estimate of 60.00 and a low estimate of 45.00. The median estimate represents a -2.49% decrease from the last price of 52.30.
The current consensus among 4 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.